Chengdu, China

Zun Wang

This inventor holds 1 USPTO granted patent. Top assignee: Systimmune, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zun Wang. Retrieved from https://idiyas.com/inventor/zun-wang-s5kpgnc7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zun Wang: Innovator in Antibody Development

Introduction

Zun Wang is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Zun Wang holds a patent for the Anti-trop2 Antibody. This invention represents a crucial step in the development of targeted therapies, potentially improving treatment options for various diseases. His patent is a testament to his innovative thinking and commitment to addressing medical challenges.

Career Highlights

Zun Wang is currently employed at Systimmune, Inc., where he continues to push the boundaries of antibody research. His work at this company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Zun Wang has worked alongside notable colleagues such as Yi Zhu and Yong Zhang. These collaborations have fostered a dynamic environment for innovation and have led to advancements in their shared research interests.

Conclusion

Zun Wang's contributions to the field of biotechnology, particularly through his patent for the Anti-trop2 Antibody, highlight his role as an influential inventor. His work at Systimmune, Inc. and collaborations with esteemed colleagues underscore his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…